First over-the-counter birth control pill coming to U.S. stores
OTC daily birth control pills will be available online and on pharmacy and store shelves nationwide later this month.
Kate Gibson is a Reporter for CBS MoneyWatch in New York, where she covers business and consumer finance. She previously worked for CNBC and MarketWatch and has written for national news outlets, including Barron's, the Wall Street Journal and the Chicago Tribune.
OTC daily birth control pills will be available online and on pharmacy and store shelves nationwide later this month.
The Daily Show host's tearful eulogy to his three-legged dog, Dipper, prompts jump in contributions to Animal Haven a no-kill shelter in New York City.
Despite local lender's woes, one analyst tamped down concerns about a repeat of 2023 banking crisis.
Popular video doorbells continue to be sold by major online retailers despite software vulnerabilities, says Consumer Reports.
City to compensate more than 15,000 people who advocates say were locked up because they were too poor to pay legal fees.
The restaurant chain misled customers about how much a delivery order would run them, a class action lawsuit alleged.
After more than 2 years of discord, Starbucks and union representing 10,000 workers jointly tout breakthrough.
Vehicle maker's fourth recall in six days seeks to address issue that can lead to parts separating from the axles.
Wendy's is reassuring customers by saying the new technology would be used to offer discounts, not to hike prices.
Discount retailer to pay largest penalty of its kind, two years after FDA investigators made unsettling discovery.
Multiple brands sold by Walmart and CVS recalled as FDA cites unsterile conditions at Indian manufacturing plant.
Storied investor says his longtime partner, the late Charlie Munger, was Berkshire Hathaway's creator.
H&R Block accused of steering tax filers to needlessly pricey products, and deleting their data when they decline.
Once worth nearly $6 billion, digital media pioneer Vice Media will stop publishing content on its website.
Antivirus software seller vowed to shield users' data from tracking, then allegedly collected and sold it instead, FTC says.